Alzamend Neuro Begins Phase II Trial for New Bipolar Disorder Treatment

Published 2 days agoALZN

Alzamend Neuro Begins Phase II Trial for New Bipolar Disorder Treatment

Alzamend Neuro has announced that it will initiate a Phase II clinical trial for AL001, its novel lithium delivery system, aimed at treating bipolar disorder (BD). The trial is set to commence in the third quarter of 2025, marking a significant step in the development of advanced treatment options for BD patients.

The trial, to be conducted at Massachusetts General Hospital, will pit AL001 against a marketed lithium carbonate product. The objective is to compare lithium blood levels and brain pharmacokinetics in patients. Preclinical studies have shown promising results, suggesting that AL001 enhances brain absorption while maintaining lower blood lithium levels, potentially reducing systemic side effects.

Alzamend Neuro CEO Stephan Jackman has highlighted the potential of AL001 to transform BD care by improving safety and brain targeting without the need for therapeutic drug monitoring. The company aims to provide a more user-friendly and effective treatment path, facilitating better patient outcomes and quality of life.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Analysts Show Optimism for Southwest Airlines with Revised Ratings

Analysts Show Optimism for Southwest Airlines with Revised Ratings

8 minutes agoLUV

Southwest Airlines has emerged in the spotlight as multiple analysts provide favorable assessments of the company's performance. Raymond James has reaffirmed an "Outperform" rating, albeit with a slight adjustment of the price target to $40.00 from $42.00, suggesting a potential upside nearing 42.76% from the current stock price. This rating comes at a time when many are closely watching the airline sector for signs of recovery and growth. Meanwhile, Morgan Stanley continues to support Southwest with an "Overweight" rating, although it has slightly reduced its price target to $38.00 from $41.00. The firm emphasized Southwest's financial resilience and its disciplined execution of strategic initiatives, asserting confidence in the airline's potential to exceed expectations moving into 2025. Argus Research's recent upgrade of Southwest Airlines from a "Hold" to a "Buy" rating, along with a price target of $35.00, underscores strong travel demand and the airline's proactive growth initiatives as key factors. These analyst ratings collectively signal an encouraging outlook on Southwest Airlines' strategic and operational trajectory. While price targets have been adjusted, the show's overall sentiment is that of confidence in the airline's market position and capability to leverage travel industry dynamics effectively. Reuters also noted the emphasis on Southwest's robust financial and strategic frameworks as central themes among these assessments.

TD Cowen Lowers Marvell Technology's Price Target to $60

TD Cowen Lowers Marvell Technology's Price Target to $60

23 minutes agoMRVL

TD Cowen has recently adjusted its price target for Marvell Technology Inc. to $60, down from a previous target of $95. This change reflects shifts in the evaluation of Marvell's market performance and potential by TD Cowen's analysts. The adjustment was made by TD Cowen's analyst, Joshua Buchalter, who pointed to a challenging market environment with limited upside potential as the primary reason for the revision. Despite the decrease, Buchalter maintains confidence in Marvell's strategic direction, supported by the company's ability to perform strongly even in a difficult sector climate, as reported by Investing.com. Marvell Technology remains focused on exceeding its Fiscal Year 2025 AI targets, demonstrating resilience and effective execution of its plans. While the revised price target highlights immediate market concerns, TD Cowen continues to hold a positive outlook on Marvell's long-term growth, particularly as demand for 5G technology expands.

Engine Capital Halts Activist Campaign as Lyft Aligns with Share Buyback Plan

Engine Capital Halts Activist Campaign as Lyft Aligns with Share Buyback Plan

38 minutes agoLYFT

Activist investor Engine Capital, which holds about 1% of Lyft's shares, has ceased its campaign to influence the company after a successful push for strategic changes. The campaign began with Engine Capital nominating two independent directors, Alan L. Bazaar and Daniel B. Silvers, to Lyft's board in April 2025, hoping to improve corporate governance and address board composition issues, Reuters reported. Engine Capital had urged Lyft to consider various strategic alternatives, including a potential sale, and criticized the dual-class share structure that offered significant voting power to the company's founders. In an effort to address the company's stock underperformance, Engine Capital proposed a $750 million accelerated share repurchase program. In response to Engine Capital’s proposal, Lyft increased its stock buyback program to the suggested $750 million in May 2025. This alignment with the activist's plan led Engine Capital to end its campaign and withdraw its board nominees, concluding the push for changes at Lyft.

SunPower's Stockholders Approve Key Measures at Annual Meeting

SunPower's Stockholders Approve Key Measures at Annual Meeting

53 minutes agoSPWR

SunPower Corporation's Annual Meeting of Stockholders, held on May 15, 2025, resulted in the approval of all proposed measures. Shareholders elected all nine director nominees to serve until the company's 2026 Annual Meeting. The meeting also confirmed BDO USA, P.C. as SunPower's independent registered public accounting firm for the fiscal year ending December 28, 2025, according to information from investors.complete.solar.com. Additionally, an amendment to the 2023 Equity Incentive Plan was passed, reserving an additional 21,555,584 shares of common stock for the plan. These decisions align with SunPower's broader strategic goals and are geared towards facilitating the company's planned financial developments over the next year.